Practice-changing therapy for IDH1/2-mutant diffuse glioma was presented at the meeting. Vorasidenib as an oral, brain penetrant, dual inhibitor of mutant IDH1/2 showed very promising results in the phase 3 INDIGO study. Other new treatment approaches including vaccines, immunotherapy and targeted ...
Practice-changing therapy for IDH1/2-mutant diffuse glioma was presented at the meeting. Vorasidenib as an oral, brain penetrant, dual inhibitor of mutant IDH1/2 showed very promising results in the phase 3 INDIGO study. Other new treatment approaches including vaccines, immunotherapy and targeted ...
被引量: 0发表: 2023年 Development of Glatopa? (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis. The multiple sclerosis (MS) treatment landscape in the United States has changed dramatically over the past decade. While many di...
Original Investigation Single-Dose Psilocybin Treatment for Major Depressive Disorder Charles L. Raison, MD; Gerard Sanacora, MD, PhD; Joshua Woolley, MD, PhD; Keith Heinzerling, MD; Boadie W. Dunlop, MD, MS; Randall T. Brown, MD, PhD; Rishi Kakar, MD; Michael Hassman, DO; Rupal P....
Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury a
on July 6, 2023, for the treatment of AD [17]. The approval of this treatment not only affirms the pathophysiological significance of amyloid in AD but also marks a notable advance in clinical approaches to AD treatment, remedying the scarcity of new drugs in the market for nearly two dec...
MS Geier,RN Butler,GS Howarth - 《International Journal of Food Microbiology》 被引量: 707发表: 2007年 New therapeutic strategies for treatment of inflammatory bowel disease New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol. 2008;1:175–82.RAtreya, M FNeurath....
The common use of empirical antibiotics has contributed to the rise of multidrug-resistant organisms, reducing treatment options and increasing costs. In addition to improved antimicrobial stewardship and the development of new antimicrobials, novel diagnostics are needed for timely microbial identification ...
Study of Diabetes (EASD) Annual Meeting. The results of the studies showed that Basalin®️is bioequivalent to Lantus®️in terms of immunogenicity, efficacy, and safety. The study adds further strong evidence to support the efficacy and safety of Basalin®️for the treatment of ...
found to improve the production of exosomes by extruding cells [130]. Furthermore, the amount of EVs produced can be enhanced by their treatment with cytochalasin B [131]. Similarly, MSC-derived exosomes treated with cytochalasin B have the same angiogenic potential to their parent MSCs [132]....